Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Rodman & Renshaw analysts initiated coverage on Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) with a Buy rating on July 21, 2026. Market Context Eledon Pharmaceuticals,…
Read moreRating Change Barclays analysts initiated coverage on Forte Biosciences, Inc. (NASDAQ:FBRX) with a Overweight rating on July 21, 2026. Market Context Forte Biosciences, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Park Aerospace Corp. (NYSE:PKE) on July 21, 2026. Market Context Park Aerospace Corp.
Read moreRating Change Northland Capital Markets analysts initiated coverage on Inflection Point Acquisition Corp. IV Unit (NASDAQ:BACQU) with a Outperform rating on July 21, 2026. Market…
Read moreRating Change Citizens analysts initiated coverage on Annexon, Inc. (NASDAQ:ANNX) with a Market Underperform rating on July 21, 2026. Market Context Annexon, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on WhiteFiber, Inc. Ordinary Shares (NASDAQ:WYFI) on July 21, 2026. Market Context WhiteFiber, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Hold rating on HealthStream, Inc. (NASDAQ:HSTM) on July 21, 2026. Market Context HealthStream, Inc.
Read moreRating Change Morgan Stanley analysts downgraded PagerDuty, Inc. (NYSE:PD) from Equal-Weight to Underweight on July 21, 2026. Market Context PagerDuty, Inc.
Read moreRating Change Jefferies analysts upgraded AdaptHealth Corp. (NASDAQ:AHCO) from Hold to Buy on July 21, 2026. Market Context AdaptHealth Corp.
Read moreRating Change Oppenheimer analysts initiated coverage on KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) with a Perform rating on July 21, 2026. Market Context KESTRA MEDICAL…
Read moreRating Change Barclays analysts reiterated a Underweight rating on Pebblebrook Hotel Trust (NYSE:PEB) on July 21, 2026. Market Context Pebblebrook Hotel Trust operates in the Real…
Read moreRating Change BTIG analysts reiterated a Buy rating on Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) on July 21, 2026. Market Context Harrow Health, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Buy rating on Relay Therapeutics, Inc. (NASDAQ:RLAY) on July 21, 2026. Market Context Relay Therapeutics, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Teladoc Health, Inc. (NYSE:TDOC) on July 21, 2026. Market Context Teladoc Health, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Par Pacific Holdings, Inc. (NYSE:PARR) on July 21, 2026. Market Context Par Pacific Holdings, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Progyny, Inc. (NASDAQ:PGNY) on July 21, 2026. Market Context Progyny, Inc.
Read moreRating Change Keybanc analysts reiterated a Overweight rating on ICU Medical, Inc. (NASDAQ:ICUI) on July 21, 2026. Market Context ICU Medical, Inc.
Read moreRating Change Morgan Stanley analysts downgraded BlackLine, Inc. (NASDAQ:BL) from Overweight to Equal-Weight on July 21, 2026. Market Context BlackLine, Inc.
Read moreRating Change Baird analysts reiterated a Neutral rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change TD Cowen analysts reiterated a Hold rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on July 21, 2026. Market Context Zions Bancorporation,…
Read more
